Skip to main content

Sight Sciences, Inc.

For the period ended Jun 30, 2026. Filed Aug 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 5, 2026

SGHT$10.75-2.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(in thousands, except share and per share data)

Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Revenue$23,388$19,564$43,086$37,072
Cost of goods sold2,0142,9774,7345,391
Gross profit21,37416,58738,35231,681
Operating expenses:
Research and development2,5124,3875,0588,817
Selling, general and administrative22,75023,86749,59548,390
Total operating expenses25,26228,25454,65357,207
Loss from operations(3,888)(11,667)(16,301)(25,526)
Investment income6781,0261,4192,174
Interest expense(1,290)(1,284)(2,557)(2,547)
Other income (expense), net822453(115)
Loss before income taxes(4,418)(11,901)(17,386)(26,014)
Provision for income taxes28404081
Net loss and comprehensive loss$(4,446)$(11,941)$(17,426)$(26,095)
Net loss per share attributable to common stockholders, basic and diluted$(0.08)$(0.23)$(0.32)$(0.51)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted54,505,79251,821,77354,225,99351,557,686
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.